KLF14 was significantly downregulated in hepatocellular carcinoma (HCC), correlating with poor prognosis, and inhibits the proliferation of HCC cells by modulating cellular iron metabolism via the repression of Iron-responsive element-binding protein 2 (IRP2) [67]. This evidence concerns the gene IREB2 and hepatocellular carcinoma.